Clinical Trials for Jacobio Pharmaceuticals

Explore 5 clinical trials worldwide

Showing 1-5 of 5 trials

Active filters:Status: Recruiting, Active, not recruiting, Enrolling by invitation, Not yet recruitingSponsor: Jacobio Pharmaceuticals

Clinical Trials (5)

NCT06973564
JAB-23E73 in Adult Participants With Advanced Solid Tumors With KRAS Alteration
PHASE1/PHASE2Not yet recruiting
294 participants
Started: May 31, 2025 · Completed: Feb 29, 2028
1 condition1 sponsor4 locations
NCT06959615
A Phase I/IIa Study of JAB-23E73 in Patients With Advanced Solid Tumors Harboring KRAS Gene Alteration
PHASE1/PHASE2Recruiting
334 participants
Started: Nov 22, 2024 · Completed: Aug 31, 2027
1 condition1 sponsor4 locations
NCT06386146
JAB-30355 in Patients With Advanced Solid Tumors Harboring TP53 Y220C Mutation
PHASE1/PHASE2Recruiting
144 participants
Started: Jul 24, 2024 · Completed: Jul 31, 2027
1 condition1 sponsor13 locations
NCT05490472
JAB-2485 Activity in Adult Patients With Advanced Solid Tumors
PHASE1/PHASE2Recruiting
102 participants
Started: Dec 20, 2022 · Completed: Aug 31, 2026
5 conditions1 sponsor5 locations
NCT05174585
JAB-BX102 Monotherapy and Combination With Pembrolizumab in Adult Patients With Advanced Solid Tumors
PHASE1/PHASE2Recruiting
62 participants
Started: Aug 18, 2022 · Completed: Mar 31, 2026
1 condition2 sponsors6 locations